Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-03-29

FDA Approved: HEATHER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for Heather (norethindrone) from Glenmark Pharmaceuticals, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEATHER (NORETHINDRONE)

Snippet

SUPPL AP for HEATHER (NORETHINDRONE)